). On Monday the company announced an early conversion of $311 million in debt into 21.76 million common shares.
Raymond James upgraded Computer Program (CPSI
) to outperform from market perform.
The FDA tentatively approved Andrx's (ADRX
) Anda for the company's generic version of Pfizer's 10 mg. Glucotrol drug for Type II diabetes. S&P reiterates accumulate. Wachovia maintains market perform.
) obtained a U.S. patent for a promoter that regulates the expression of the human telomerase reverse transcriptase gene. The patent triggers a milestone payment from Cell Genesys, which holds a non-exclusive license to the promoter.
Siebel Systems (SEBL
) announced the settlement of a derivative lawsuit, and the adoption of corporate government initiatives. S&P reiterates hold.
Comtech Telecommunications (CMTL
) sees better than expected 24 cents to 26 cents fourth-quarter EPS on $51 million sales. It notes sales in the mobile data communications services segment far exceeded expectations. CE Unterberg raised its estimates.
Engineered Support Systems (EASI
) posted 72 cents vs. 43 cents third-quarter EPS from continuing operations on a 46% revenue rise. It raised the 2003 EPS guidance to $2.40 to $2.45, on revenue of at least $550 million.
Jefferies upgraded Chicago Mercantile Exchange (CME
) to buy from hold.
Dycom Industries (DY
) posted 24 cents fourth-quarter earnings per share (GAAP basis; including an increase in allowance for doubtful accounts and an impairment charge) vs. $1.19 loss per share on 23% higher contract revenues. Dycom sees 22 cents to 27 cents first-quarter earnings per share on $135 million to $150 million revenues. Merrill upgraded to buy from neutral.
) posted an 11-cent fourth-quarter loss (including a charge) vs. $1.00 earnings per share (restated) on a 36% revenue drop. AmeriCredit restated the 30 cents nine-month earnings per share ended March 31, 2003 earnings per share to 29 cents, and restated the $3.87 fiscal 2002 earnings per share to $3.50. AmeriCredit sees $55 million to $70 million in 12-month net income (ended Dec. 31).
SG Cowen upgraded Xerox (XRX
) to buy.
Myriad Genetics (MYGN
) posted a 26-cent fourth-quarter loss vs. a 29-cent loss on an 11% total revenue rise. Credit Suisse First Boston downgraded to neutral.
Medical device maker Guidant (GDT
) reaffirmed the 52 cents to 57 cents third-quarter earnings per share, the $2.27 to $2.37 2003 earnings per share (adjusted) guidance. Gudiant plans to repurchase up to $250 million shares next year.
Toll Brothers (TOL
) posted 90 cents vs. 70 cents third-quarter earnings per share on a 19% revenue rise -- ahead of the 81 cents earnings per share consensus estimate. The homebuilder says it's on pace for record results in fiscal 2003 and the next several years.
) says a new study showed treatment with its Aricept significantly improved memory, thinking, and global function in patients with vascular dementia, compared with a placebo.
) posted 1 cent fourth-quarter earnings per share vs. a 25-cent loss on a 50% total revenue rise. Digene sees 2 cents to 4 cents first-quarter pre-tax earnings per share on $19 million to $20.5 million revenue.
A U.S. district court in California ruled that Vanguard laser-sintering systems, manufactured by DTM Corp, which 3D Systems (TDSC
) acquired in August, 2001, infringes patent rights held by Germany's EOS GmbH. 3D Systems is liable for any damages.
Resource Bankshares (RBKV
) agreed to be acquired by Fulton Financial in a $195.6 million deal. Terms: 2.2 Fulton shares for each Resource Bankshares share.
) posted 50 cents vs. 45 cents fourth-quarter earnings per share on a 17% consolidated revenue rise. The hair-salon chain sees 50 cents to 52 cents first-quarter earnings per share on a 15% to 16% consolidated revenue rise. Regis raised the stock repurchase program to $100 million, from $50 million.